Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram‐negative bacterial sepsis in burned mice
- 1 January 1993
- Vol. 101 (1-6) , 229-234
- https://doi.org/10.1111/j.1699-0463.1993.tb00105.x
Abstract
A human intravenous IgG preparation (Anti-LPS IgG) rich in antibodies to different lipopolysaccharides (LPS) and a normal human intravenous IgG (NIgG) were investigated for their ability to confer passive immunity. Both preparations were given at the time of infection (prophylaxis) or during sepsis (therapy) to burned mice with lethal infection induced by various clinically relevant gram-negative bacteria. When given at the time of infection both IgG preparations (5 mg/mouse) inhibited lethality induced by some bacteria (Pseudomonas aeruginosa serogroup G and B), but not others (Serratia marcescens, Klebsiella pneumonia, Proteus mirabilis), indicating a protection by by strain-specific antibodies. However, no significant protection was seen when mice were treated during sepsis. The range of specific antibody titers to the whole live bacteria and heat-killed (LPS-preserved) bacteria in the NIgG paralleled that of Anti-LPS IgG; however, the magnitude of the antibody titers did not accurately reflect the protective capacity in vivo. Thus, the exact specificity of the protective antibodies is still unknown. The protective effect of both IgG preparations was dose-dependent; at low IgG doses (0.5 mg/mouse) better protection was obtained with Anti-LPS IgG, whilst at higher doses (> or = 1 mg/mouse) both preparations exhibited identical effects. Low doses of either IgG preparation in combination with subtherapeutic doses of piperacillin significantly enhanced early survival (day 2 for NIgG and day 2 + 3 for Anti-LPS IgG) against P. aeruginosa, but the protective effect waned thereafter. We conclude that a strain-specific antibacterial effect in a compromised mouse infection model can be obtained by early passive immunization with human IgG from large plasma pools. It is suggested that Anti-LPS IgG or NIgG may be of benefit in some cases of gram-negative sepsis when administered as prophylaxis together with proper antibiotic treatment.Keywords
This publication has 18 references indexed in Scilit:
- Comparison of pre- versus post-sepsis treatment with polyclonal immunoglobulin versus O serotype specific monoclonal antibody in burned Pseudomonas aeruginosa infected miceSerodiagnosis and Immunotherapy in Infectious Disease, 1990
- Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharidesAPMIS, 1989
- Immunochemical and Biological Reactivity of Human Anti-Lipopolysaccharide IgG Obtained by Screening of Blood DonorsScandinavian Journal of Immunology, 1989
- Preliminary Study on Treatment of Septic Shock Patients with Antilipopolysaccharide IgG from Blood DonorsScandinavian Journal of Infectious Diseases, 1989
- Antibody Activity, Contained in a Commercial Pseudomonas Hyperimmune Globulin Product, Against Various Members of the Family EnterobacteriaceaeJournal of Burn Care & Rehabilitation, 1988
- Elisa for Human IgG and IpM Anti-Lipopolysaccharide Antibodies with Indirect StandardizationJournal of Immunoassay, 1987
- Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: passive intravenous immunotherapy using pseudomonas globulinSerodiagnosis and Immunotherapy in Infectious Disease, 1987
- The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, CincinnatiCanadian Journal of Microbiology, 1985
- Gram-Negative Bacteraemia: New Therapeutic Possibilities with Anti-Endotoxin AntibodiesPublished by Springer Nature ,1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982